Our achievements. Our accomplishments. Our impact.



  • Evidence-Based Policy Making

    When the Stem Cell Network launched in 2001, its most pressing goal was to address the policy vacuum that was constraining stem cell research in Canada. SCN and its members provided credible, research-based evidence and recommendations that were critical in the development of Canada’s regulatory landscape for stem cell research.

    READ STORY

  • Public Engagement

    The Stem Cell Network has elevated the level of public discourse and understanding about stem cells in Canada by engaging Canadians in artistic, accessible and innovative explorations of emerging issues in the field and by becoming an active and respected presence online.

    READ STORY

  • Patient Engagement

    The Stem Cell Network engaged world-leading researchers and ethicists to provide Canadians with credible and accessible information on the latest advancements in stem cell research.

    READ STORY

  • Drug Discovery and Repurposing

    The Stem Cell Network was among the first organizations to recognize the potential of using stem cells for drug repositioning and discovery in order to reduce time and costs of bringing new therapies to patients, and in the process has established Canada as a world leader in the field.

    READ STORY

  • Clinical Trials

    When the Stem Cell Network was first funded, its leadership considered that catalyzing a single clinical trial during its 14-year mandate would have been a success. Instead, the Network’s research investments have led to 12 clinical trials on various diseases, with even more in the development pipeline.

    READ STORY

  • Ethical, Legal and Social Issues

    SCN established and funded a world-leading arms-length research program to examine the key social, legal and ethical implications of stem cell research and, based upon this credible and research-based evidence, has provided critical policy recommendations to government that have impacted not only how research is conducted in Canada, but how Canadians will access potential therapies in the future.

    READ STORY